CD8A and Huntington disease: To determine whether plasma soluble factors in BC patients could regulate the percentage and the cytotoxic/pro-inflammatory activity of CD8+ HLA-DR+ T cells, we cultured HD PBMCs in the presence of plasma from HD, R or NR patients.